Хірургічне втручання у пацієнтів, які проходять антитромбоцитарну терапію 4 страница

199. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B,­Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV,­Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting­and bare metal stents: comprehensive meta-analysis of randomized trials and observational­studies. Circulation 2009;119(25):3198–3206

200. Moses JW, Mehran R, Nikolsky E, Lasala JM, CoreyW, Albin G, Hirsch C, Leon MB,­Russell ME, Ellis SG, Stone GW. Outcomes with the paclitaxel-eluting stent in­patients with acute coronary syndromes: analysis from the TAXUS-IV trial. J Am­Coll Cardiol 2005;45(8):1165–1171

201. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di­Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH,­Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ,­Mahaffey KW, Valgimigli M, van ’t Hof A, Widimsky P, Zahger D. ESC Guidelines­for the management of acute myocardial infarction in patients presenting with­ST-segment elevation. Eur Heart J 2012;33(20):2569–2619

202. Gershlick AH, Banning AP, Myat A, Verheugt FW, Gersh BJ. Reperfusion therapy­for STEMI: is there still a role for thrombolysis in the era of primary percutaneous­coronary intervention? Lancet 2013;382(9892):624–632

203. Miedema MD, Newell MC, Duval S, Garberich RF, Handran CB, Larson DM,­Mulder S,Wang YL, Lips DL, Henry TD. Causes of delay and associated mortality­in patients transferred with ST-segment-elevation myocardial infarction. Circulation­2011;124(15):1636–1644

204. Herrin J, Miller LE, Turkmani DF, NsaW, Drye EE, BernheimSM, Ling SM, RappMT,­HanLF, BratzlerDW, Bradley EH, Nallamothu BK, TingHH,KrumholzHM.National­performance on door-in to door-out time among patients transferred for­primary percutaneous coronary intervention. Arch Intern Med 2011;171(21):­1879–1886

205. Wang TY, Nallamothu BK, Krumholz HM, Li S, Roe MT, Jollis JG, Jacobs AK,­Holmes DR, Peterson ED, Ting HH. Association of door-in to door-out time­with reperfusion delays and outcomes among patients transferred for primary percutaneous­coronary intervention. JAMA 2011;305(24):2540–2547

206. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr., Chung MK, de Lemos JA,­Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM,­Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ,­Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL,­Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D,­Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Stevenson WG, Yancy CW 2013ACCF/AHA guideline for the management of ST-elevation myocardial infarction:­a report of the American College of Cardiology Foundation/American Heart­Association Task Force on Practice Guidelines. Circulation 2013;127(4):e362–­e425

207. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in­acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;­348(9030):771–775

208. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing­primary percutaneous coronary intervention and in-hospital fibrinolysis in­acute myocardial infarction patients. Eur Heart J 2006;27(7):779–788

209. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous­coronary interventions for ST-elevation myocardial infarction: quantitative­review of randomised trials. Lancet 2006;367(9510):579–588

210. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, Cattan S,­Boullenger E, Machecourt J, Lacroute JM, Cassagnes J, Dissait F, Touboul P. Primary­angioplasty vs. prehospital fibrinolysis in acute myocardial infarction: a randomised­study. Lancet 2002;360(9336):825–829

211. Bonnefoy E, Steg PG, Boutitie F, Dubien PY, Lapostolle F, Roncalli J, Dissait F,­Vanzetto G, Leizorowicz A, Kirkorian G, Mercier C, McFadden EP, Touboul P Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial­infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009;30(13):­1598–1606

212. Morrison LJ, Verbeek PR, McDonaldAC, Sawadsky BV, CookDJ. Mortality and prehospital­thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 2000;­283(20):2686–2692

213. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P,­Leizorovicz A, Touboul P. Impact of time to treatment on mortality after prehospital­fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical­trial. Circulation 2003;108(23):2851–2856

214. Pinto DS, Frederick PD, Chakrabarti AK, Kirtane AJ, Ullman E, Dejam A, Miller DP,­Henry TD, Gibson CM. Benefit of transferring ST-segment-elevation myocardial­infarction patients for percutaneous coronary intervention compared with administration­of onsite fibrinolytic declines as delays increase. Circulation 2011;124(23):­2512–2521

215. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y,­Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J,­Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A,­Vandenberghe K, Bogaerts K, Van de Werf F. Fibrinolysis or primary PCI in­ST-segment elevation myocardial infarction. N Engl J Med 2013;368(15):­1379–1387

216. Bates ER, Jacobs AK. Time to treatment in patients with STEMI. N Engl J Med 2013;­369(10):889–892

217. Luepker RV, Raczynski JM, Osganian S, Goldberg RJ, Finnegan JR Jr., Hedges JR,­Goff DC Jr., Eisenberg MS, Zapka JG, Feldman HA, Labarthe DR, McGovern PG,­Cornell CE, Proschan MA, Simons-Morton DG. Effect of a community intervention­on patient delay and emergency medical service use in acute coronary heart­disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA­2000;284(1):60–67

218. Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario C, Wijns W,­Clemmensen P, Agladze V, Antoniades L, Alhabib KF, De Boer MJ, Claeys MJ,­Deleanu D, Dudek D, Erglis A, Gilard M, Goktekin O, Guagliumi G, Gudnason T,­Hansen KW, Huber K, James S, Janota T, Jennings S, Kajander O, Kanakakis J,­Karamfiloff KK, Kedev S, Kornowski R, Ludman PF, Merkely B, Milicic D,­Najafov R, Nicolini FA, Noc M, Ostojic M, Pereira H, Radovanovic D, Sabate M,­Sobhy M, Sokolov M, Studencan M, Terzic I, Wahler S, Widimsky P. Reperfusion­therapy for ST elevation acute myocardial infarction 2010/2011: current status in­37 ESC countries. Eur Heart J 2014;35:1957–1970

219. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P,­Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR,­Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS. A comparison­of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 2003;349(8):733–742

220. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty­vs. immediate thrombolysis in acute myocardial infarction: a meta-analysis Circulation 2003;108(15):1809–1814

221. Hochman JS, Sleeper LA,Webb JG, Sanborn TA, White HD, Talley JD, Buller CE,­Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in­acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators ShouldWe Emergently Revascularize Occluded Coronaries for Cardiogenic­Shock. N Engl J Med 1999;341(9):625–634

222. Mehilli J, Kastrati A, Schulz S, Frungel S, Nekolla SG, MoshageW, Dotzer F, Huber K,­Pache J, Dirschinger J, Seyfarth M, Martinoff S, Schwaiger M, Schomig A. Abciximab­in patients with acute ST-segment-elevation myocardial infarction undergoing­primary percutaneous coronary intervention after clopidogrel loading: a randomized­double-blind trial. Circulation 2009;119(14):1933–1940

223. Busk M, Kaltoft A, Nielsen SS, Bottcher M, Rehling M, Thuesen L, Botker HE,­Lassen JF, Christiansen EH, Krusell LR, Andersen HR, Nielsen TT, Kristensen SD Infarct size and myocardial salvage after primary angioplasty in patients presenting­with symptoms for,12 h vs. 12–72 h. Eur Heart J 2009;30(11):1322–1330

224. Schomig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F,­Nekolla SG, Schlotterbeck K, Schuhlen H, Pache J, Seyfarth M, Martinoff S,­BenzerW, Schmitt C, Dirschinger J, Schwaiger M, Kastrati A. Mechanical reperfusion­in patients with acute myocardial infarction presenting more than 12 hours­from symptom onset: a randomized controlled trial. JAMA 2005;293(23):­2865–2872

225. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, SchreiberW, Unger G,­Glogar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J,Weber HS, Huber K Implementation of guidelines improves the standard of care: the Viennese registry­on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI­registry). Circulation 2006;113(20):2398–2405

226. Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, Lips DL,­Madison JD, Menssen KM, Mooney MR, Newell MC, Pedersen WR, Poulose AK,­Traverse JH, Unger BT, Wang YL, Larson DM. A regional system to provide­timely access to percutaneous coronary intervention for ST-elevation myocardial­infarction. Circulation 2007;116(7):721–728

227. Nallamothu BK, Krumholz HM, Ko DT, LaBresh KA, Rathore S, Roe MT,­Schwamm L. Development of systems of care for ST-elevation myocardial infarction­patients: gaps, barriers, and implications. Circulation 2007;116(2):e68–e72

228. Widimsky P, WijnsW, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G,­Baz JA, Betriu A, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K,­Kala P, Klinceva M, Kristensen SD,Ludman P, Ferre JM, Merkely B, Milicic D, Morais J,­Noc M, Opolski G, Ostojic M, Radovanovic D, De Servi S, Stenestrand U,­Studencan M, Tubaro M, Vasiljevic Z,Weidinger F, Witkowski A, Zeymer U. Reperfusion­therapy for ST elevation acute myocardial infarction in Europe: description­of the current situation in 30 countries. Eur Heart J 2010;31(8):943–957

229. Knot J, Widimsky P, Wijns W, Stenestrand U, Kristensen SD, Van THA,­Weidinger F, Janzon M, Norgaard BL, Soerensen JT, van de Wetering H,­Thygesen K, Bergsten PA, Digerfeldt C, Potgieter A, Tomer N, Fajadet J. How to­set up an effective national primary angioplasty network: lessons learned from­five European countries. EuroIntervention 2009;5(3):299, 301–309

230. Bradley EH, Herrin J,Wang Y, Barton BA,Webster TR, Mattera JA, Roumanis SA,­Curtis JP, Nallamothu BK, Magid DJ, McNamara RL, Parkosewich J, Loeb JM,­Krumholz HM. Strategies for reducing the door-to-balloon time in acute myocardial­infarction. N Engl J Med 2006;355(22):2308–2320

231. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE,­Bates ER, Frederick PD, Miller DP, Carrozza JP Jr., Antman EM, Cannon CP,­Gibson CM. Hospital delays in reperfusion for ST-elevation myocardial infarction:­implications when selecting a reperfusion strategy. Circulation 2006;114(19):­2019–2025

232. Steg PG, Cambou JP, Goldstein P, Durand E, Sauval P, Kadri Z, Blanchard D,­Lablanche JM, Gueret P, Cottin Y, Juliard JM, Hanania G, Vaur L, Danchin N. Bypassing­the emergency room reduces delays and mortality in ST elevation myocardial­infarction: the USIC 2000 registry. Heart 2006;92(10):1378–1383

233. Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention­during primary percutaneous coronary intervention for ST-segment elevation­myocardial infarction (from the National Cardiovascular Data Registry). Am J­Cardiol 2009;104(4):507–513

234. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, Gersh BJ,­Wong SC, Witzenbichler B, Guagliumi G, Dudek D, Fahy M, Lansky AJ,­Stone GW. Prognostic impact of staged vs. "one-time" multivessel percutaneous­intervention in acute myocardial infarction: analysis from the HORIZONS-AMI­(harmonizing outcomes with revascularization and stents in acute myocardial infarction)­trial. J Am Coll Cardiol 2011;58(7):704–711

235. Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Leuzzi C, Bursi F, Sangiorgi GM,­Modena MG. A randomised trial of target-vessel vs. multi-vessel revascularisation­in ST-elevation myocardial infarction: major adverse cardiac events during longterm­follow-up. Heart 2010;96(9):662–667

236. Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P, Emanuela P, Stefano DS,­Angelo R, Stefania C, Anna F, Carmelo C, Antonio C,Monzini N, Bonardi MA. Single­vs.multivessel treatment during primary angioplasty: results of the multicentre randomised­HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction­(HELP AMI) Study. Int J Cardiovasc Intervent 2004;6(3–4):128–133

237. Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, Budaj A, Niemela M,­Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD,­Chrolavicius S, Mehta SR. Radial vs. femoral access for coronary angiography and­intervention in patients with acute coronary syndromes (RIVAL): a randomised,­parallel group, multicentre trial. Lancet 2011;377(9775):1409–1420

238. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G,­Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P,­Lioy E, Sheiban I, Sangiorgi G. Radial vs. femoral randomized investigation in­ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Vs Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome)­study. J Am Coll Cardiol 2012;60(24):2481–2489

239. Baklanov DV, Kaltenbach LA, Marso SP, Subherwal SS, Feldman DN, Garratt KN,­Curtis JP, Messenger JC, Rao SV. The prevalence and outcomes of transradial percutaneous­coronary intervention for ST-segment elevation myocardial infarction:­analysis from the National Cardiovascular Data Registry (2007 to 2011). J Am Coll­Cardiol 2013;61(4):420–426

240. Hamon M, Pristipino C, Di Mario C, Nolan J, Ludwig J, Tubaro M, Sabate M,­Mauri-Ferre J, Huber K, Niemela K, Haude M, Wijns W, Dudek D, Fajadet J,­Kiemeneij F. Consensus document on the radial approach in percutaneous cardiovascular­interventions: position paper by the European Association of Percutaneous­Cardiovascular Interventions and Working Groups on Acute Cardiac­Care** and Thrombosis of the European Society of Cardiology. EuroIntervention­2013;8(11):1242–1251

241. Nordmann AJ, Hengstler P, Harr T, Young J, Bucher HC. Clinical outcomes of­primary stenting vs. balloon angioplasty in patients with myocardial infarction: a­meta-analysis of randomized controlled trials. Am J Med 2004;116(4):253–262

242. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G,­Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ. Comparison of angioplasty­with stenting, with or without abciximab, in acute myocardial infarction. N­Engl J Med 2002;346(13):957–966

243. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D,­Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Fahy M,­Parise H, Mehran R. Heparin plus a glycoprotein IIb/IIIa inhibitor vs. bivalirudin­monotherapyand paclitaxel-eluting stents vs. bare-metal stents in acute myocardial­infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised­controlled trial. Lancet 2011;377(9784):2193–2204

244. Kalesan B, Pilgrim T, Heinimann K, Raber L, Stefanini GG, Valgimigli M, da Costa BR,­Mach F, Luscher TF, Meier B, Windecker S, Juni P. Comparison of drug-eluting­stents with bare metal stents in patients with ST-segment elevation myocardial infarctionEur Heart J 2012;33(8):977–987

245. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary­responses and differential mechanisms of late stent thrombosis attributed to firstgeneration­sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57(4):­390–398

246. Hofma SH, Brouwer J, Velders MA, van’t Hof AW, Smits PC, Quere M, de Vries CJ,­van Boven AJ. Second-generation everolimus-eluting stents vs. first-generation­sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized­XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial­Infarction) trial. J Am Coll Cardiol 2012;60(5):381–387

247. Sabate M, Cequier A, Iniguez A, Serra A, Hernandez-Antolin R, Mainar V,­Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N,­Gomez-Hospital JA, Baz JA, Martin-Yuste V, van Geuns RJ, Alfonso F, Bordes P,­Tebaldi M, Masotti M, Silvestro A, Backx B, Brugaletta S, van Es GA, Serruys PW Everolimus-eluting stent vs. bare-metal stent in ST-segment elevation myocardial­infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 2012;380(9852):1482–1490

248. Raber L, Kelbaek H, Ostojic M, Baumbach A, Heg D, Tuller D, von Birgelen C,­Roffi M, Moschovitis A, Khattab AA, Wenaweser P, Bonvini R, Pedrazzini G,­Kornowski R, Weber K, Trelle S, Luscher TF, Taniwaki M, Matter CM, Meier B,­Juni P, Windecker S. Effect of biolimus-eluting stents with biodegradable polymer­vs.bare-metal stents on cardiovascular events among patients with acute myocardial­infarction: the COMFORTABLE AMI randomized trial. JAMA 2012;308(8):­777–787

249. Sabate M, Raber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, Ostojic M, Iniguez A,­Tuller D, Serra A, Baumbach A, von Birgelen C, Hernandez-Antolin R, Roffi M,­Mainar V, Valgimigli M, Serruys PW, Juni P, Windecker S. Comparison of Newer-­Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute­ST-Segment Elevation Myocardial Infarction: A Pooled Analysis of the EXAMINATION­(clinical Evaluation of the Xience-V stent in Acute Myocardial INfArc-­TION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an­Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial­Infarction) Trials. JACC Cardiovasc Interv 2014;7(1):55–63

250. Vlaar PJ, Svilaas T, van der Horst IC, Diercks GF, Fokkema ML, de Smet BJ, van den­Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. Cardiac­death and reinfarction after1 year in the Thrombus Aspiration during Percutaneous­coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year­follow-up study. Lancet 2008;371(9628):1915–1920

251. Sardella G, Mancone M, Bucciarelli-Ducci C, Agati L, Scardala R, Carbone I,­Francone M, Di Roma A, Benedetti G, Conti G, Fedele F. Thrombus aspiration­during primary percutaneous coronary intervention improves myocardial reperfusion­and reduces infarct size: the EXPIRA (thrombectomy with export catheter in­infarct-related artery during primary percutaneous coronary intervention) prospective,­randomized trial. J Am Coll Cardiol 2009;53(4):309–315

252. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F. Adjunctive­manual thrombectomy improves myocardial perfusion and mortality in patients­undergoing primary percutaneous coronary intervention for ST-elevation­myocardial infarction: a meta-analysis of randomized trials. Eur Heart J 2008;­29(24):3002–3010

253. Costopoulos C, Gorog DA, Di Mario C, Kukreja N. Use of thrombectomy devices­in primary percutaneous coronary intervention: a systematic review and­meta-analysis. Int J Cardiol 2013;163(3):229–241

254. De Luca G, Navarese EP, Suryapranata H. A meta-analytic overview of thrombectomy­during primary angioplasty. Int J Cardiol 2013;166(3):606–612

255. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic­protection devices in acute myocardial infarction: a comprehensive meta-analysis­of randomized trials. Eur Heart J 2008;29(24):2989–3001

256. Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M,­Aasa M, Angeras O, Calais F, Danielewicz M, Erlinge D, Hellsten L, Jensen U,­Johansson AC, Karegren A, Nilsson J, Robertson L, Sandhall L, Sjogren I,­Ostlund O, Harnek J, James SK. Thrombus aspiration during ST-segment elevation­myocardial infarction. N Engl J Med 2013;369(17):1587–1597

257. Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, Iwaoka R, Azrin M,­Stapleton D, Setum C, Popma J. Rheolytic thrombectomy with percutaneous coronary­intervention for infarct size reduction in acute myocardial infarction: 30-day­results from a multicenter randomized study. JAmColl Cardiol 2006;48(2):244–252

258. Migliorini A, Stabile A, Rodriguez AE, Gandolfo C, Rodriguez Granillo AM,­Valenti R, Parodi G, Neumann FJ, Colombo A, Antoniucci D. Comparison of Angio-­Jet rheolytic thrombectomy before direct infarct artery stenting with direct stenting­alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll­Cardiol 2010;56(16):1298–1306

259. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M,­Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, Krucoff MW,­Gibbons RJ, Jones D, Lansky AJ, Mehran R. Distal microcirculatory protection­during percutaneous coronary intervention in acute ST-segment elevation myocardial­infarction: a randomized controlled trial. JAMA 2005;293(9):1063–1072

260. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ,­Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH,­Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT,­Redington AN, Nielsen TT. Remote ischaemic conditioning before hospital admission,­as a complement to angioplasty, and effect on myocardial salvage in patients­with acute myocardial infarction: a randomised trial. Lancet 2010;375(9716):­727–734

261. Ibanez B, Macaya C, Sanchez-Brunete V, Pizarro G, Fernandez-Friera L, Mateos A,­Fernandez-Ortiz A, Garcia-Ruiz JM, Garcia-Alvarez A, Iniguez A,­Jimenez-Borreguero J, Lopez-Romero P, Fernandez-Jimenez R, Goicolea J,­Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vazquez JA, Rodriguez MD,­Escalera N, Acebal C, Cabrera JA, Valenciano J, Perez de Prado A,­Fernandez-Campos MJ, Casado I, Garcia-Rubira JC, Garcia-Prieto J, Sanz-Rosa D,­Cuellas C, Hernandez-Antolin R, Albarran A, Fernandez-Vazquez F, de la­Torre-Hernandez JM, Pocock S, Sanz G, Fuster V. Effect of Early Metoprolol on­Infarct Size in ST-Segment-Elevation Myocardial Infarction Patients Undergoing­Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection­During an Acute Myocardial Infarction (METOCARD-CNIC) Trial Circulation 2013;128(14):1495–1503

262. vanWerkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ,­Koolen JJ, Brueren BR, Dambrink JH, HautvastRW, VerheugtFW, ten Berg JM. Predictors­of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am­Coll Cardiol 2009;53(16):1399–1409

263. Stone GW, Abizaid A, Silber S, Dizon JM, Merkely B, Costa RA, Kornowski R,­Wojdyla R, Maehara A, Dressler O, Brener SJ, Bar E, Dudek D. Prospective, Randomized,­Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-­Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The­MASTER Trial. J Am Coll Cardiol 2012;60:1975–1984

264. Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr., Jacobs AK, Stamato NJ,­Venditti FJ, Sharma S, King SB 3rd. Culprit vessel percutaneous coronary intervention­vs. multivessel and staged percutaneous coronary intervention for ST-segment­elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc­Interv 2010;3(1):22–31

265. Toma M, Buller CE, Westerhout CM, Fu Y, O’Neill WW, Holmes DR Jr.,­Hamm CW, Granger CB, Armstrong PW. Non-culprit coronary artery percutaneous­coronary intervention during acute ST-segment elevation myocardial infarction:­insights from the APEX-AMI trial. Eur Heart J 2010;31(14):1701–1707

266. Vlaar PJ, Mahmoud KD, Holmes DR Jr., van Valkenhoef G, Hillege HL, van der­Horst IC, Zijlstra F, de Smet BJ. Culprit vessel only vs. multivessel and staged percutaneous­coronary intervention for multivessel disease in patients presenting­with ST-segment elevation myocardial infarction: a pairwise and network­meta-analysis. J Am Coll Cardiol 2011;58(7):692–703

267. Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, Berry C,­Oldroyd KG. Randomized trial of preventive angioplasty in myocardial infarction N Engl J Med 2013;369(12):1115–1123

268. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabate M, Valgimigli M,­Frati G, Kedhi E, Smits PC, Kaiser C, Genereux P, Galatius S, Kirtane AJ,­Stone GW. Clinical outcomes with drug-eluting and bare-metal stents in patients­with ST-segme nt elevation myocardial infarction: evidence from a comprehensive­network meta-analysis. J Am Coll Cardiol 2013;62(6):496–504

269. Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di­Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT,­Percoco G, Varricchio A, Pittl U, Syvanne M, Suttorp MJ, Violini R, Schomig A Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in­patients with acute myocardial infarction. Eur Heart J 2007;28(22):2706–2713

270. KarrowniW, Vyas A, Giacomino B, Schweizer M, Blevins A, Girotra S, Horwitz PA Radial vs. femoral access for primary percutaneous interventions in ST-segment­elevation myocardial infarction patients: a meta-analysis of randomized controlled­trials. JACC Cardiovasc Interv 2013;6(8):814–823

271. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L,­Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O,­Neunteufl T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR,­Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med­2008;358(21):2205–2217

272. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA,­Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A,­Goodman SG. Routine early angioplasty after fibrinolysis for acute myocardial infarction N Engl J Med 2009;360(26):2705–2718

273. Di Mario C,Dudek D, Piscione F, MieleckiW, Savonitto S, Murena E, Dimopoulos K,­Manari A, Gaspardone A, Ochala A, Zmudka K, Bolognese L, Steg PG, Flather M Immediate angioplasty vs. standard therapy with rescue angioplasty after thrombolysis­in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction­(CARESS-in-AMI): an open, prospective, randomised, multicentre trial Lancet 2008;371(9612):559–568

274. Bohmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and safety­of immediate angioplasty vs. ischemia-guided management after thrombolysis in­acute myocardial infarction in areas with very long transfer distances results of­theNORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial­infarction). J Am Coll Cardiol 2010;55(2):102–110

275. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, Vazquez N, Blanco J,­Alonso-Briales J, Lopez-Mesa J, Fernandez-Vazquez F, Calvo I, Martinez-Elbal L,­San Roman JA, Ramos B. Routine invasive strategy within 24 hours of thrombolysis­vs. ischaemia-guided conservative approach for acute myocardial infarction with­ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004;­364(9439):1045–1053

276. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, Maloney J,­McKibbin T, Quinn B, Beanlands RS, Glover C, Marquis JF, O’Brien ER,­Williams WL, Higginson LA. Combined angioplasty and pharmacological intervention­vs. thrombolysis alone in acute myocardial infarction (CAPITAL AMI study) J Am Coll Cardiol 2005;46(3):417–424

277. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, Winter H,­Nickenig G, Bohm M. Beneficial effects of immediate stenting after thrombolysis­in acute myocardial infarction. J Am Coll Cardiol 2003;42(4):634–641

278. Borgia F, Goodman SG, Halvorsen S, Cantor WJ, Piscione F, Le May MR,­Fernandez-Aviles F, Sanchez PL, Dimopoulos K, Scheller B, Armstrong PW, Di­Mario C. Early routine percutaneous coronary intervention after fibrinolysis vs standard therapy in ST-segment elevation myocardial infarction: a meta-analysis Eur Heart J 2010;31(17):2156–2169

279. Collet JP, Montalescot G, Le May M, Borentain M, Gershlick A. Percutaneous coronary­intervention after fibrinolysis: a multiple meta-analyses approach according­to the type of strategy. J Am Coll Cardiol 2006;48(7):1326–1335

280. D’Souza SP, Mamas MA, Fraser DG, Fath-Ordoubadi F. Routine early coronary­angioplasty vs. ischaemia-guided angioplasty after thrombolysis in acute­ST-elevation myocardial infarction: a meta-analysis. Eur Heart J 2011;32(8):­972–982

281. Desch S, Eitel I, Rahimi K, deWaha S, Schuler G, Thiele H. Timing of invasive treatment­after fibrinolysis in ST elevation myocardial infarction:a meta-analysis of immediate­or early routine vs. deferred or ischemia-guided randomised controlled­trials. Heart 2010;96(21):1695–1702

282. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, de­Belder A, Davis J, Pitt M, Banning A, Baumbach A, ShiuMF, Schofield P, DawkinsKD,­Henderson RA, Oldroyd KG, Wilcox R. Rescue angioplasty after failed thrombolytic­therapy for acute myocardial infarction. N Engl J Med 2005;353(26):­2758–2768

283. Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG,­Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S,­Forman R, Desvigne-Nickens P, Jacobs AK, Slater JN, LeJemtel TH. One-year survival­following early revascularization for cardiogenic shock. JAMA 2001;285(2):­190–192

Не нашли, что искали? Воспользуйтесь поиском: